BOSTON--(BUSINESS WIRE)--Nov. 24, 2020--
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Chief Executive Officer of Gamida Cell, will present at two virtual conferences in December:
Evercore ISI 3rd Annual HealthCONx Conference, fireside chat at 12:10 p.m. ET on December 3, 2020
Piper Sandler 32nd Annual Healthcare Conference, on December 1st-3rd, 2020. Company fireside chat will be available to view on-demand throughout the duration of the conference.
A webcast of each presentation will be available in the “Investors & Media” section of the Gamida Cell website, www.gamida-cell.com, and will be available for at least 14 days following the event.
About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com or follow Gamida Cell on LinkedIn or Twitter at @GamidaCellTx.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201124005285/en/
Stern Investor Relations, Inc.
Matthew Corcoran (media)
Source: Gamida Cell Ltd